Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
A. Cárdenas, R. Ortega, P. Ginés.
The hepatocirculatory syndrome and the management of patients with ascites.
Therapy in hepatology, pp. 33-42
[2.]
R.J. Groszmann.
Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences.
Hepatology, 20 (1994), pp. 1359-1363
[3.]
P. Gines, G. Fernández-Esparrach.
Prognosis of cirrhosis with ascites.
Ascites and renal dysfunction in liver disease, pp. 431-441
[4.]
M. Bernardi, F. Trevsiani.
Systemic and regional hemodynamics in pre-ascitic cirrhosis.
J Hepatol, 27 (1997), pp. 588-591
[5.]
F. Lee, R. Groszmann.
Experimental models in the investigation of portal hypertension.
Ascites and renal dysfunction in liver disease, pp. 365-378
[6.]
F. Scaffner, H. Popper.
Capillarization of hepatic sinusoids in man.
Gastroenterology, 44 (1963), pp. 239-242
[7.]
H. Reynaert, M.G. Thompson, T. Thomas, A. Geerts.
Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension.
Gut, 50 (2002), pp. 571-581
[8.]
D.C. Rockey.
New concepts in the pathogenesis of portal hypertension: hepatic wounding and stellate cell contractility.
Clin Liver Dis, 1 (1997), pp. 13-29
[9.]
R. Wiest, R.J. Groszmann.
Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance.
Semin Liver Dis, 19 (1999), pp. 411-426
[10.]
D.C. Rockey, J.J. Chung.
Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension.
Gastroenterology, 114 (1998), pp. 344-351
[11.]
J. Vorobioff, J.E. Bredfeldt, R.J. Groszmann.
Increased blood flow through the portal system in cirrhotic rats.
Gastroenterology, 87 (1984), pp. 1120-1126
[12.]
R.J. Korthuis, D.A. Kinden, G.E. Brimer, K.A. Slattery, P. Stogsdill, D.N. Granger.
Intestinal capillary filtration in acute and chronic portal hypertension.
Am J Physiol, 254 (1988), pp. 339-345
[13.]
J.N. Benoit, D.N. Granger.
Intestinal microvascular adaptation to chronic portal hypertension in the rat.
Gastroenterology, 94 (1988), pp. 471-476
[14.]
R. Jalan, E.H. Forrest, D.N. Redhead, J.F. Dillon, P.C. Hayes.
Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man?.
Gut, 40 (1997), pp. 664-670
[15.]
G. La Villa, J.M. Salmerón, V. Arroyo, J. Bosch, P. Ginés, J.C. García-Pagán, et al.
Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension.
Gastroenterology, 102 (1992), pp. 2114-2119
[16.]
J.N. Benoit, D.N. Granger.
Splanchnic hemodynamics in chronic portal hypertension.
Semin Liver Dis, 6 (1986), pp. 287-298
[17.]
J.H. Henriksen, F. Bendtsen, T.I.A. Sorensen, C. Stadeager, H. Ring-Larsen.
Reduced central blood volume in cirrhosis.
Gastroenterology, 97 (1989), pp. 1506-1513
[18.]
J.H. Henriksen, F. Bendtsen, A.L. Gerbes, N.J. Christensen, H. Ring-Larsen, T.I. Sorensen.
Estimated central blood volume in cirrhosis: relationship to sympathetic nervous activity, beta adrenergic blockade and atrial natriuretic factor.
Hepatology, 16 (1992), pp. 1163-1170
[19.]
S. Moller, L. Sondergaard, J. Mogelvang, O. Henriksen, J.H. Henriksen.
Decreased right heart blood volume determined by magnetic resonance imaging: evidence of central underfilling in cirrhosis.
Hepatology, 22 (1995), pp. 472-478
[20.]
M. Guevara, P. Ginés, G. Fernández-Esparrach, P. Sort, R. Bataller, W. Jiménez, et al.
Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion.
Hepatology, 27 (1998), pp. 35-41
[21.]
J. Uriz, P. Ginés, A. Cárdenas, P. Sort, W. Jiménez, J.M. Salmerón, et al.
Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome.
J Hepatol, 33 (2000), pp. 43-48
[22.]
R. Ortega, P. Ginés, J. Uriz, A. Cárdenas, B. Clahorra, D. De las Heras, et al.
Terlipressin therapy with and without albumin for patients with hepatorenal syndrome. Results of a prospective, non-randomized study.
Hepatology, 36 (2002), pp. 941-948
[23.]
A. Ginés, A. Escorsell, P. Ginés, J. Saló, W. Jiménez, L. Inglada, et al.
Incidence, predictive factors, and prognosis of hepatorenal syndrome in cirrhosis.
Gastroenterology, 105 (1993), pp. 229-236
[24.]
P. Ginés, J. Rodés.
Clinical disorders of renal function in cirrhosis with ascites.
Ascites and renal dysfunction in liver disease, pp. 36-62
[25.]
L. Caregaro, F. Menon, P. Angeli, P. Amodio, C. Merkel, A. Bortoluzzi, et al.
Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis.
Arch Intern Med, 154 (1994), pp. 201-205
[26.]
D. Sacerdoti, M. Bolognesi, C. Merkel, P. Angeli, A. Gatta.
Renal vasoconstriction in cirrhosis evaluated by Duplex Doppler ultrasonography.
Hepatology, 17 (1993), pp. 219-224
[27.]
K.V. Menon, P.S. Kamath.
Regional and systemic hemodynamic disturbances in cirrhosis.
Clin Liver Dis, 5 (2001), pp. 617-627
[28.]
M. Fallon, G. Abrams.
Pulmonary dysfunction in chronic liver disease.
Hepatology, 32 (2000), pp. 859-865
[29.]
M. Guevara, C. Bru, P. Ginès, G. Fernández-Esparrach, P. Sort, R. Bataller, et al.
Increased cerebrovascular resistance in cirrhotic patients with ascites.
Hepatology, 28 (1998), pp. 39-44
[30.]
A. Maroto, P. Ginés, V. Arroyo, A. Ginés, J. Saló, J. Clària, et al.
Brachial and femoral artery blood flow in cirrhosis: relationship to kidney dysfunction.
Hepatology, 17 (1993), pp. 788-793
[31.]
T. Iwao, A. Toyonaga, M. Sato, K. Oho, T. Sakai, C. Tayama, et al.
Effect of posture-induced blood volume expansion on systemic and regional hemodynamic alterations in cirrhosis.
J Hepatol, 27 (1997), pp. 484-491
[32.]
C.M. Fernández-Rodríguez, J. Prieto, J.M. Zozaya, J. Quiroga, R. Guitián.
Arteriovenous shunting, hemodynamic changes, and renal sodium retention in liver cirrhosis.
Gastroenterology, 104 (1993), pp. 1139-1145
[33.]
M. Knotek, B. Rogachev, R.W. Schrier.
Update on peripheral arterial vasodilation, ascites and hepatorenal syndrome in cirrhosis.
Can J Gastroenterol, 14 (2000), pp. 112-121
[34.]
N. Hori, T. Okanoue, Y. Sawa, K. Kashima.
Role of calcitonin gene-related peptide in the vascular system on the development of the hyperdynamic circulation in conscious cirrhotic rats.
J Hepatol, 26 (1997), pp. 1111-1119
[35.]
C.M. Fernández-Rodríguez, J. Prieto, J. Quiroga, J.M. Zozoya, A. Andrade, M. Núñez, et al.
Plasma levels of substance P in liver cirrhosis: relationship to the activation of vasopressor systems and urinary sodium excretion.
Hepatology, 21 (1995), pp. 35-40
[36.]
M. Guevara, P. Ginés, W. Jiménez, P. Sort, G. Fernández-Esparrach, A. Escorsell, et al.
Increased adrenomedullin levels in cirrhosis: relationship with hemodynamic abnormalities and vasoconstrictor systems.
Gastroenterology, 114 (1998), pp. 336-343
[37.]
M. Suematsu, N. Goda, T. Sano, S. Kashiwagi, T. Egawa, Y. Shinoda, et al.
Carbon monoxide: an endogenous modulator of sinusoidal tone in the perfused rat liver.
J Clin Invest, 96 (1995), pp. 2431-2437
[38.]
M. Fernández, H.L. Bonkovsky.
Increased heme oxygenase activity in splanchnic organs from portal hypertensive rats: role in modulating mesenteric vascular reactivity.
J Hepatol, 34 (2001), pp. 812-817
[39.]
N. Makino, M. Suematsu, Y. Sugiura, H. Morikawa, S. Shiomi, N. Goda, et al.
Altered expression of heme oxygenase-1 in the livers of patients with portal hypertensive diseases.
Hepatology, 33 (2001), pp. 32-42
[40.]
D. De las Heras, R. Ortega, P. Ginés, A. Cárdenas.
Increased systemic production of carbon monoxide in patients with cirrhosis and ascites with and without spontaneous bacterial peritonitis (SBP).
J Hepatol, 36 (2002), pp. 34A
[41.]
P. Vallance, S. Moncada.
Hyperdynamic circulation in cirrhosis: a role for nitric oxide?.
Lancet, 337 (1991), pp. 776-778
[42.]
P.Y. Martin, P. Ginés, R.W. Schrier.
Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis.
N Engl J Med, 339 (1998), pp. 533-570
[43.]
J. Ros, W. Jiménez, S. Lamas, J. Claria, V. Arroyo, F. Rivera, et al.
Nitric oxide production in arterial vessels of cirrhotic rats.
Hepatology, 21 (1995), pp. 554-560
[44.]
M. Niederberger, P. Ginès, P. Tsai, P.Y. Martin, K. Morris, A. Weigert, et al.
Increased aortic cyclic guanosine monophosphate concentration in experimental cirrhosis in rats: evidence for a role of nitric oxide in the pathogenesis of arterial vasodilation in cirrhosis.
Hepatology, 21 (1995), pp. 1625-1631
[45.]
C.C. Sieber, J.C. López-Talavera, R.J. Groszmann.
Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats.
Gastroenterology, 104 (1993), pp. 1750-1754
[46.]
N.M. Atucha, V. Shah, G. García-Cárdena, et al.
Role of endothelium in the abnormal response of mesenteric vessels in rats with portal hypertension and liver cirrhosis.
Gastroenterology, 111 (1996), pp. 1627-1632
[47.]
N. Hori, R. Wiest, R.J. Groszmann.
Enhanced release of nitric oxide in response to changes in flow and shear stress in the superior mesenteric arteries of portal hypertensive rats.
Hepatology, 28 (1998), pp. 1467-1473
[48.]
G. García-Tsao, F.Y. Lee, G.E. Barden, A. West.
Bacterial translocation in acute and chronic portal hypertension.
Gastroenterology, 108 (1995), pp. 1835-1841
[49.]
R. Wiest, S. Das, G. Cadelina, G. García-Tsao, S. Milstien, R.J. Groszmann.
Bacterial translocation in cirrhotic rats stimulates e NOS-derived NO production and impairs mesenteric cascular contractility.
J Clin Invest, 104 (1999), pp. 1223-1233
[50.]
M. Niederberger, P.Y. Martin, P. Ginès, K. Morris, P. Tsai, D.L. Xu, et al.
Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in rats with cirrhosis and ascites.
Gastroenterology, 109 (1995), pp. 1624-1630
[51.]
P.Y. Martin, M. Ohara, P. Ginés, et al.
Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites.
J Clin Invest, 101 (1998), pp. 235-242
[52.]
S. Battista, F. Bar, G. Mengozzi, et al.
Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitric oxide levels in hepatic and portal veins.
J Hepatol, 26 (1997), pp. 75-80
[53.]
C. Guarner, G. Soriano, A. Tomás, et al.
Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship with endotoxemia.
Hepatology, 18 (1993), pp. 1139-1143
[54.]
P. Sogni, P. Garnier, A. Gadano, et al.
Endogenous pulmonary nitric oxide production measured from exhaled air is increased in patients with severe cirrhosis.
J Hepatol, 23 (1995), pp. 471-473
[55.]
A. Matsumoto, K. Ogura, Y. Hirata, et al.
Increased nitric oxide in the exhaled air of patients with decompensated liver cirrhosis.
Ann Intern Med, 123 (1995), pp. 110-113
[56.]
B. Campillo, P.E. Chabrier, G. Pelle, et al.
Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis.
Hepatology, 22 (1995), pp. 1423-1429
[57.]
G. La Villa, E. Barletta, P. Pantaleo, et al.
Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
Hepatology, 34 (2001), pp. 19-27
[58.]
L. Spahr, P.Y. Martin, E. Giostra, et al.
Acute effects of nitric oxide synthase inhibition on systemic, hepatic, and renal hemodynamics in patients with cirrhosis and ascites.
J Investig Med, 50 (2002), pp. 116-124
[59.]
P. Schenk, C. Madl, S. Rezale-Majd, S. Lehr, C. Muller.
Methylene blue improves hepatopulmonary syndrome.
Ann Int Med, 133 (2000), pp. 701-703
[60.]
A. Cárdenas, P. Ginés.
Treatment of water retention and dilutional hyponatremia in cirrhosis.
Treatment of liver diseases, pp. 61-71
[61.]
V. Arroyo, J. Rodés, M.A. Gutiérrez-Lizarraga, L. Revert.
Prognostic value of spontaneous hyponatremia in cirrhosis with ascites.
Am J Dig Dis, 21 (1976), pp. 249-256
[62.]
R.W. Schrier, V. Arroyo, M. Bernardi, M. Epstein, J.H. Henriksen, J. Rodés.
Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.
Hepatology, 8 (1988), pp. 1151-1157
[63.]
G. Fernández-Esparrach, A. Sánchez-Fueyo, P. Ginés, J. Uriz, L. Quinto, P.J. Ventura.
A prognostic model for predicting survival in cirrhosis.
J Hepatol, 34 (2001), pp. 46-52
[64.]
J. Llach, P. Ginés, V. Arroyo, A. Rimola, L. Titó, S. Badalamenti, et al.
Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites.
Gastroenterology, 88 (1988), pp. 514-519
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados
